Prime Medicine, Inc.

PRME Nasdaq SEC CIK 1894562
Follow Prime Medicine Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $4.2M +243.9% vs same quarter last year
Net income −$39M +22.8% vs same quarter last year
EPS, diluted −$0.22 +31.3% vs same quarter last year
Operating cash flow −$36.7M −4.7% vs same quarter last year
Revenue by quarter
$2.2M
$1.5M
$1.1M
$1.2M
$838K
$4.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$300M−$200M−$100M$0$100MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$4.6M−$201.1M
FY24$3M−$195.9M
FY23$0−$198.1M
FY22$0−$121.8M
FY21$0−$165.4M
FY20$5.2M−$3.4M
FY19--
MarginsShare of revenue
  • Operating margin
  • Net margin
−8000%−6000%−4000%−2000%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−4498.1%−4342.4%
FY24−6787.4%−6566.6%
FY23--
FY22--
FY21--
FY20−17.9%−65.5%
FY19--
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$167.1M
FY24−$130.2M
FY23−$174.1M
FY22−$147.9M
FY21−$38.2M
FY20−$6.2M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Prime Medicine
  • Healthcare median
−8000%−6000%−4000%−2000%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearPrime MedicineHealthcare median
FY25−4342.4%−30.6%
FY24−6566.6%−47%
FY23-−58%
FY22-−80.4%
FY21-−71.8%
FY20−65.5%−62.2%
FY19-−46.2%